EMA
safety_alert
· 2020-11-13
Ulipristal acetate for uterine fibroids: EMA recommends restricting use
Summary
EMA recommends restricting the use of ulipristal acetate for uterine fibroids due to safety concerns.
Upgrade for the full analysis, importance score, and drug timeline.